Notice of Decision for TRETTEN
Health Canada Notice of Decision July 30, 2012, Tretten, catridecacog, 15 mg/vial, lyophilized powder, Novo Nordisk Canada Inc., Submission Control No. 152228
Health Canada RSS – Drug Products, Drugs and Health Products
Category: Health Canada
Subscribe
If you enjoyed this article, subscribe to receive more just like it.
